pharmaceutical investing Alexion Announces Successful Phase 3 PREVENT Study of Soliris (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder
pharmaceutical investing Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU
Gemdale Gold Expands Land Position in Finland and Recommences Exploration in the Central Lapland Greenstone Belt
Standard Uranium Provides Drilling Update on the 2026 Drill Program at Flagship Davidson River Project - Announces Elevated Radioactivity in First Drill Hole
